Skip to main content
. 2017 Mar-Apr;21(2):341–354. doi: 10.4103/ijem.IJEM_512_16

Table 4.

Expert group recommendation 4: Dose modification of meglitinides in chronic liver disease

graphic file with name IJEM-21-341-g006.jpg